These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 37767840)

  • 1. [Clinical and prognostic relevance of integrated cardiac imaging in hypertrophic cardiomyopathy].
    Orazio G; Erriquez A; Campo G
    G Ital Cardiol (Rome); 2023 Oct; 24(10):e. PubMed ID: 37767840
    [No Abstract]   [Full Text] [Related]  

  • 2. Myocardial radionuclide imaging in patients with hypertrophic cardiomyopathy.
    Cai M; Tian YQ; He ZX
    Nucl Med Commun; 2013 Apr; 34(4):298-305. PubMed ID: 23358478
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cardiac MR Imaging of Hypertrophic Cardiomyopathy: Techniques, Findings, and Clinical Relevance.
    Amano Y; Kitamura M; Takano H; Yanagisawa F; Tachi M; Suzuki Y; Kumita S; Takayama M
    Magn Reson Med Sci; 2018 Apr; 17(2):120-131. PubMed ID: 29343659
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cardiac fibroblast activation imaging in a patient with hypertrophic cardiomyopathy.
    Zhang Y; Wang YL; Yang MF; Wang L
    J Nucl Cardiol; 2023 Aug; 30(4):1697-1699. PubMed ID: 35415823
    [No Abstract]   [Full Text] [Related]  

  • 5. Late Gadolinium Enhancement-Dispersion Mapping: A New Magnetic Resonance Imaging Technique to Assess Prognosis in Patients With Hypertrophic Cardiomyopathy and Low-Intermediate 5-Year Risk of Sudden Death.
    Aquaro GD; Grigoratos C; Bracco A; Proclemer A; Todiere G; Martini N; Habtemicael YG; Carerj S; Sinagra G; Di Bella G
    Circ Cardiovasc Imaging; 2020 Jun; 13(6):e010489. PubMed ID: 32539460
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Complementary Role of Echocardiography and Cardiac Magnetic Resonance in Hypertrophic Cardiomyopathy.
    Hindieh W; Chan R; Rakowski H
    Curr Cardiol Rep; 2017 Sep; 19(9):81. PubMed ID: 28752280
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Global Longitudinal Strain and Left Atrial Volume Index Provide Incremental Prognostic Value in Patients With Hypertrophic Cardiomyopathy.
    Hiemstra YL; Debonnaire P; Bootsma M; van Zwet EW; Delgado V; Schalij MJ; Atsma DE; Bax JJ; Marsan NA
    Circ Cardiovasc Imaging; 2017 Jul; 10(7):. PubMed ID: 28679523
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Imaging techniques in the evaluation and management of hypertrophic cardiomyopathy.
    Kelley-Hedgepeth A; Maron MS
    Curr Heart Fail Rep; 2009 Sep; 6(3):135-41. PubMed ID: 19723454
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of Demographic, Clinical, Biochemical, and Imaging Findings in Hypertrophic Cardiomyopathy Prognosis: A Network Meta-Analysis.
    Georgiopoulos G; Figliozzi S; Pateras K; Nicoli F; Bampatsias D; Beltrami M; Finocchiaro G; Chiribiri A; Masci PG; Olivotto I
    JACC Heart Fail; 2023 Jan; 11(1):30-41. PubMed ID: 36599547
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Clinical Prognosis of Presence and Location of Late Gadolinium Enhancement by Cardiac Magnetic Resonance Imaging in Patients with Hypertrophic Cardiomyopathy: a Single-Center Cohort Study.
    Li X; Lai L; Luo R; Yang H; Ma H; Yang Z; Zhao S; Su W; Hua W
    J Cardiovasc Transl Res; 2021 Oct; 14(5):1001-1016. PubMed ID: 33629154
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic significant of indium-111 antimyosin antibody uptake in patients with dilated and hypertrophic cardiomyopathy.
    Matsumori A; Yamada T; Tamaki N; Watanabe Y; Yonekura Y; Endo K; Konishi J; Yoshida A; Kawai C
    Int J Cardiol; 1991 Jul; 32(1):75-81. PubMed ID: 1864672
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The role of cardiovascular magnetic resonance imaging in the diagnosis of hypertrophic cardiomyopathy. Part I].
    Pleva M; Borová J; Plevová I; Januška J; Belicová M
    Vnitr Lek; 2017; 63(3):194-198. PubMed ID: 28379022
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Myocardial tissue characterization by gadolinium-enhanced cardiac magnetic resonance imaging for risk stratification of adverse events in hypertrophic cardiomyopathy.
    Raiker N; Vullaganti S; Collins JD; Allen BD; Choudhury L
    Int J Cardiovasc Imaging; 2020 Jun; 36(6):1147-1156. PubMed ID: 32166506
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hypertrophic Cardiomyopathy: A Review.
    Bazan SGZ; Oliveira GO; Silveira CFDSMPD; Reis FM; Malagutte KNDS; Tinasi LSN; Bazan R; Hueb JC; Okoshi K
    Arq Bras Cardiol; 2020 Nov; 115(5):927-935. PubMed ID: 33295458
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The role of real-time three-dimensional echocardiography in the evaluation of hypertrophic cardiomyopathy].
    Nemes A; Geleijnse ML; Soliman OI; Anwar AM; Vletter WB; McGhie JS; Csanády M; Forster T; Ten Cate FJ
    Orv Hetil; 2009 Oct; 150(42):1925-31. PubMed ID: 19812010
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical and echocardiographic features of hypertrophic cardiomyopathy in the elderly.
    Lewis JF
    Am J Geriatr Cardiol; 2001; 10(1):11-7; quiz 17-9. PubMed ID: 11413932
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic relevance of exercise testing in hypertrophic cardiomyopathy. A systematic review.
    Rodrigues T; Raposo SC; Brito D; Lopes LR
    Int J Cardiol; 2021 Sep; 339():83-92. PubMed ID: 34214502
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Treatment of hypertrophic cardiomyopathy].
    Havndrup O; Bundgaard H; Hansen FV; Pietersen AH; Kelbaek HS
    Ugeskr Laeger; 1998 Sep; 160(38):5495-500. PubMed ID: 9763923
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognosis of hypertrophic cardiomyopathy.
    Ten Cate FJ
    J Insur Med; 1996; 28(1):42-5. PubMed ID: 10163618
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Echocardiography for hypertrophic cardiomyopathy.
    Patil PV; Wiegers SE
    Prog Cardiovasc Dis; 2014; 57(1):91-9. PubMed ID: 25081404
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.